Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 4, 1997, Pages 889-893

  Hallak, M ^a   Senderowicz, J ^a   Cassel, A ^a   Shapira, C ^a   Aghai, E ^a   Auslender, R ^a   Abramovici, H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Factor V Leiden; pregnancy; thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; FIBRINOGEN; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HUMAN; LUNG EMBOLISM; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; PUERPERIUM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 0030911640     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70617-3     Document Type: Article

References (21)

1. KG Mann RJ Jenny S Krishnaswamy Cofactor proteins in the assembly and expression of blood clotting enzyme complexes Annu Rev Biochem 57 1988 915 956
2. PW Majerus Bad blood by mutation Nature 369 1994 14 15
3. B Dahlbäck M Carlsson PJ Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci U S A 90 1993 1004 1008
4. IH Griffin B Evatt C Wideman JA Fernandez Anticoagulant protein C pathway defective in majority of thrombophilic patients Blood 82 1993 1989 1993
5. EM Faioni F Franchi D Asti E Sacchi F Bernardi PM Mannucci Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay Thromb Haemost 70 1993 1067 1071
6. PJ Svensson B Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
7. T Koster FR Rosendaal Activated protein C resistance in venous thrombosis Lancet 343 1994 541
8. T Koster FR Rosendaal H de Ronde E Briet JP Vandenbroucke RM Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study Lancet 342 1993 1503 1506
9. B Dahlback B Hildebrand Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V Proc Natl Acad Sci U S A 91 1994 1396 1400
10. X Sun B Evatt JH Griffin Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia Blood 83 1994 3120 3125
11. RJ Laros Jr Thromboembolic disease 3rd ed RK Creasy R Resnik Maternal-fetal medicine: principles and practice 1994 WB Saunders Philadelphia 792 803
12. RM Bertina BPC Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
13. 506 of factor V Lancet 343 1994 1535 1536
14. JS Greengard S Eichinger JH Griffin KA Bauer Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V N Engl J Med 331 1994 1559 1562
15. H de Ronde RM Bertina Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria Thromb Haemost 72 1994 880 886
16. JS Greengard X Sun JA Fernandez IH Griffin B Evatt Activated protein C resistance caused by Arg506Gln mutation in factor Va Lancet 343 1994 1361 1362
17. R Baker J Thom F van Bockxmeer Diagnosis of activated protein C resistance (factor V Leiden) Lancet 344 1994 1162
18. JI Jorquera IM Montoro MA Fernandez JA Aznar J Aznar Modified test for activated protein C resistance Lancet 344 1994 1162 1163
19. C Legnani G Palareti R Biagi S Coccheri Activated protein C resistance in deep-vein-thrombosis Lancet 343 1994 541 542
20. B Lindblad PJ Svensson B Dahlback Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C Lancet 343 1994 917
21. JP Vandenbroucke T Koster E Briet PH Reitsma RM Bertina FR Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457